125 results
S-8
EX-23.1
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
with respect to our audit of internal control over financial reporting of Viking Therapeutics, Inc. as of December 31, 2023 appearing in the Annual Report
8-K
EX-1.1
owk 6e638revjo
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
S-8
EX-23.1
cpprger06o0myo714d36
7 Feb 24
Registration of securities for employees
5:33pm